Clinical Services > Pharmacy

Hospital pharmacists' role in COVID-19 treatments

23 March, 2022 by Kristin Michaels, SHPA Chief Executive

The introduction of oral antiviral treatments calls on the expertise and services of hospital pharmacists as we progress towards the endemic stage of this pandemic.


WA pharmacist recognised for leadership, contribution to medical safety

16 March, 2022

Kerry Fitzsimons has been recognised by the Society of Hospital Pharmacists of Australia (SHPA) for her leadership and contribution to medical safety in Western Australia and beyond.


SHPA releases pharmacy standard for heart disease

08 March, 2022

The new pharmacy practice standard recommends patient to pharmacist ratios and quality improvement indicators specific to specialist cardiology pharmacists.


Royal Victorian Eye and Ear Hospital implements PSML

07 March, 2022

The Royal Victorian Eye and Ear Hospital is said to be the first hospital in Australia to implement the Pharmacist Shared Medicines List medicine safety initiative.


New rare blood disease treatment on PBS

28 February, 2022

Ultomiris (ravulizumab) will be listed for the first time for patients with paroxysmal nocturnal haemoglobinuria.


Bill to shore up medicine supplies: SHPA

03 December, 2021

The Society of Hospital Pharmacists of Australia (SHPA) has welcomed new federal government legislation to further mitigate the impact of medicine shortages on Australians and ensure new and innovative medicines are accessible, available and affordable.


More expert pharmacists needed in the era of medicine miracles

23 September, 2021 by Kristin Michaels, SHPA Chief Executive

As we live through the lengthening tail of a persistent pandemic, it is challenging to consider the simpler medicines landscape of 20 years ago.


Aus antimicrobial use decreasing but not enough: report

27 August, 2021

While antimicrobial use in the community is decreasing, overprescribing and inappropriate prescribing continue to be problematic.


Review of National Medicines Policy after 22 years

04 August, 2021

For the first time since its development in 1999, Australia's National Medicines Policy is set for review.


Speed up pharmacy vaccine rollout to end lockdown, says report

21 July, 2021

Accelerating the rollout of vaccines into pharmacies could help Australia reach its vaccination target of 80% up to two months faster than current projections.


Medicinal cannabis facility planned for Toowoomba

12 July, 2021

Medibis has announced long-term plans to build a multi-million-dollar medicinal cannabis facility in Toowoomba, Queensland.


Metabolic hormone leptin linked to vaccine response

31 May, 2021 by Amy Sarcevic

Reduced levels of the metabolic hormone leptin may be responsible for poor vaccine efficacy among certain individuals, according to a new study.


New COVID-19 vaccine completely blocks viral transmission

19 May, 2021 by Amy Sarcevic

An Adelaide-based company has developed a COVID-19 vaccine that completely blocks viral transmission to individuals who lack immunity, as well as offering protection for those inoculated.


Historic PBS listing of cannabis for Dravet syndrome

10 May, 2021

Epidyolex has been added to the Pharmaceutical Benefits Scheme (PBS) for the treatment of Dravet syndrome, a rare and drug-resistant form of epilepsy.


New national standard for intensive care pharmacists

05 May, 2021

The standardised guidelines place pharmacists as key members of the multidisciplinary medical team caring for patients in the ICU.


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd